DEXCHLORPHENIRAMINE MALEATE

DEXCHLORPHENIRAMINE MALEATE was reported 1005 times

DEXCHLORPHENIRAMINE MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EMPHYSEMATOUS BULLA 1 0.1429
1 HEPATITIS B SURFACE ANTIGEN NEGATIVE 1 0.1250
2 DIFFUSE CUTANEOUS MASTOCYTOSIS 2 0.0667
3 HEPATIC VEIN STENOSIS 2 0.0500
4 HERPES SEPSIS 1 0.0435
5 HAEMOPHILUS BACTERAEMIA 2 0.0408
6 ENDOTOXAEMIA 1 0.0385
7 EXANTHEMA SUBITUM 1 0.0294
8 COOMBS INDIRECT TEST POSITIVE 2 0.0270
9 EAR, NOSE AND THROAT INFECTION 2 0.0244
10 AUTOIMMUNE CHOLANGITIS 1 0.0227
11 LACTATE PYRUVATE RATIO INCREASED 1 0.0217
12 BLOOD KETONE BODY DECREASED 1 0.0213
13 PULMONARY HILUM MASS 4 0.0213
14 ENGRAFT FAILURE 6 0.0209
15 HYPOZINCAEMIA 1 0.0169
16 CUTIBACTERIUM ACNES INFECTION 1 0.0169
17 KAWASAKI'S DISEASE 1 0.0132
18 NECROTISING RETINITIS 8 0.0125
19 PURPURA NON-THROMBOCYTOPENIC 1 0.0120
20 EYELID EROSION 1 0.0115
21 FALSE POSITIVE LABORATORY RESULT 2 0.0108
22 ANAPHYLACTOID SHOCK 5 0.0106
23 BLOOD CORTICOTROPHIN ABNORMAL 1 0.0104
24 ISCHAEMIC ENTERITIS 1 0.0103
25 ANAL POLYP 1 0.0097
26 MONOCYTOPENIA 1 0.0096
27 ANAL EROSION 1 0.0091
28 ALLERGIC BRONCHITIS 1 0.0090
29 ABDOMINAL WALL CYST 1 0.0082
30 DIARRHOEA NEONATAL 1 0.0079
31 HAEMOPHILUS TEST POSITIVE 1 0.0078
32 ENTEROCOLITIS BACTERIAL 2 0.0072
33 OEDEMA DUE TO CARDIAC DISEASE 1 0.0071
34 FIBRIN DEGRADATION PRODUCTS INCREASED 2 0.0068
35 CHRONIC TONSILLITIS 1 0.0065
36 BLOOD BETA-D-GLUCAN INCREASED 2 0.0065
37 DACRYOCYSTITIS 1 0.0065
38 ADAMS-STOKES SYNDROME 1 0.0065
39 IMMUNOLOGY TEST ABNORMAL 1 0.0064
40 LYMPHORRHOEA 1 0.0064
41 ALLOGENIC STEM CELL TRANSPLANTATION 1 0.0063
42 MYODESOPSIA 1 0.0063
43 MENINGITIS HERPES 1 0.0061
44 ELECTROMYOGRAM ABNORMAL 1 0.0055
45 GAMMOPATHY 1 0.0055
46 ILEITIS 2 0.0052
47 ANAEMIA FOLATE DEFICIENCY 1 0.0052
48 CYTOMEGALOVIRUS TEST POSITIVE 9 0.0050
49 SUPERINFECTION BACTERIAL 4 0.0050
50 PRIMARY HYPOTHYROIDISM 1 0.0047
51 OCULOMUCOCUTANEOUS SYNDROME 2 0.0047
52 PNEUMONIA NECROTISING 3 0.0046
53 HISTAMINE LEVEL INCREASED 1 0.0046
54 VICTIM OF CHEMICAL SUBMISSION 3 0.0045
55 NEUTROPENIA NEONATAL 1 0.0045
56 MUCOCUTANEOUS ULCERATION 1 0.0044
57 EPIDERMOLYSIS 2 0.0043
58 MONONEUROPATHY MULTIPLEX 2 0.0043
59 FEBRILE BONE MARROW APLASIA 18 0.0042
60 CARDIAC FAILURE HIGH OUTPUT 1 0.0041
61 ICHTHYOSIS 1 0.0040
62 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 7 0.0040
63 ADENOIDAL DISORDER 1 0.0038
64 RED BLOOD CELL SEDIMENTATION RATE DECREASED 1 0.0038
65 ACUTE INTERSTITIAL PNEUMONITIS 2 0.0038
66 HEPATITIS C ANTIBODY POSITIVE 1 0.0037
67 HYPERAMYLASAEMIA 2 0.0037
68 ANTITHROMBIN III DECREASED 1 0.0037
69 COOMBS TEST POSITIVE 1 0.0037
70 TYPE III IMMUNE COMPLEX MEDIATED REACTION 2 0.0036
71 MEAN PLATELET VOLUME DECREASED 3 0.0036
72 CARBUNCLE 1 0.0035
73 ACUTE POLYNEUROPATHY 1 0.0035
74 HYPOURICAEMIA 1 0.0034
75 INFUSION RELATED HYPERSENSITIVITY REACTION 2 0.0033
76 URINARY TRACT INFECTION PSEUDOMONAL 2 0.0033
77 ASPERGILLUS TEST POSITIVE 1 0.0032
78 DEVICE RELATED BACTERAEMIA 1 0.0032
79 SKIN TEST POSITIVE 3 0.0032
80 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 3 0.0032
81 PAPILLOMA 1 0.0032
82 OSTEITIS DEFORMANS 1 0.0031
83 GASTROINTESTINAL MUCOSAL DISORDER 2 0.0031
84 METABOLIC FUNCTION TEST ABNORMAL 1 0.0030
85 NEUROLOGICAL DECOMPENSATION 7 0.0030
86 LARYNGOMALACIA 1 0.0030
87 REDUCED FACIAL EXPRESSION 3 0.0030
88 CIRCUMORAL OEDEMA 1 0.0029
89 OCULOGYRIC CRISIS 6 0.0028
90 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
91 CERVICAL CORD COMPRESSION 1 0.0028
92 ALTERNARIA INFECTION 1 0.0027
93 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
94 COLON CANCER METASTATIC 4 0.0025
95 ENTEROCOCCAL SEPSIS 2 0.0025
96 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
97 METASTASES TO THE MEDIASTINUM 1 0.0024
98 PERITONSILLAR ABSCESS 2 0.0024
99 GASTRODUODENAL ULCER 1 0.0024
100 CITROBACTER INFECTION 1 0.0023
101 NEUROSIS 1 0.0022
102 PRURIGO 2 0.0022
103 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
104 ECZEMA HERPETICUM 1 0.0022
105 MASTOCYTOSIS 1 0.0021
106 HYPOPROTEINAEMIA 4 0.0021
107 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
108 ELECTROLYTE DEPLETION 1 0.0020
109 PNEUMONIA PNEUMOCOCCAL 3 0.0020
110 GLARE 1 0.0019
111 CYTOKINE RELEASE SYNDROME 39 0.0019
112 PROCEDURAL SITE REACTION 1 0.0019
113 FUNGAEMIA 3 0.0019
114 ELECTROENCEPHALOGRAM ABNORMAL 6 0.0019
115 ENTEROCOCCAL BACTERAEMIA 2 0.0019
116 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
117 EXOMPHALOS 1 0.0019
118 RECTAL PERFORATION 1 0.0019
119 B-CELL LYMPHOMA RECURRENT 1 0.0018
120 SERUM SICKNESS 5 0.0018
121 PSEUDOMEMBRANOUS COLITIS 4 0.0018
122 BODY TINEA 1 0.0018
123 ENCEPHALOMALACIA 1 0.0018
124 GAZE PALSY 3 0.0018
125 SENSE OF OPPRESSION 2 0.0017
126 PNEUMOCOCCAL INFECTION 1 0.0017
127 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 1 0.0017
128 MIXED LIVER INJURY 5 0.0017
129 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
130 GENERALISED ERYTHEMA 9 0.0016
131 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
132 ASPERGILLOSIS 2 0.0015
133 NON-HODGKIN'S LYMPHOMA 2 0.0015
134 FASCIITIS 1 0.0015
135 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
136 POSTOPERATIVE ADHESION 1 0.0015
137 INFUSION SITE URTICARIA 1 0.0015
138 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
139 CYSTITIS HAEMORRHAGIC 6 0.0015
140 HEPATITIS B DNA INCREASED 1 0.0015
141 NEUTROPENIC COLITIS 3 0.0014
142 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
143 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
144 FLUID IMBALANCE 1 0.0014
145 DERMATITIS DIAPER 1 0.0014
146 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
147 HEPATOCELLULAR INJURY 20 0.0014
148 LARYNGEAL DISORDER 1 0.0014
149 ESCHERICHIA SEPSIS 4 0.0014
150 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 8 0.0013
151 IMPETIGO 2 0.0013
152 KOUNIS SYNDROME 3 0.0013
153 HYPOALBUMINAEMIA 10 0.0013
154 METAPNEUMOVIRUS INFECTION 1 0.0013
155 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 1 0.0013
156 BLOOD FIBRINOGEN INCREASED 1 0.0013
157 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
158 HEPATITIS VIRAL 1 0.0012
159 HERPES ZOSTER DISSEMINATED 1 0.0012
160 PLACENTAL INSUFFICIENCY 1 0.0012
161 ARTERIOSPASM CORONARY 5 0.0012
162 LIVER ABSCESS 4 0.0012
163 ALLERGIC GRANULOMATOUS ANGIITIS 1 0.0012
164 HYPERURICAEMIA 5 0.0012
165 MYCOSIS FUNGOIDES 1 0.0012
166 ANAPHYLACTOID REACTION 5 0.0012
167 SEBORRHOEIC DERMATITIS 2 0.0012
168 COLLAPSE OF LUNG 1 0.0012
169 CYTOLYTIC HEPATITIS 4 0.0012
170 CAMPYLOBACTER INFECTION 1 0.0012
171 FUNGAL SEPSIS 1 0.0012
172 TONSILLAR HYPERTROPHY 2 0.0012
173 AMAUROSIS 1 0.0012
174 HEPATITIS A 1 0.0012
175 HYPERTHERMIA 9 0.0012
176 FIXED ERUPTION 2 0.0012
177 TYPE I HYPERSENSITIVITY 4 0.0011
178 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
179 PARVOVIRUS B19 INFECTION 1 0.0011
180 CANDIDA SEPSIS 1 0.0011
181 HYPERPLASIA 1 0.0011
182 EXTENSOR PLANTAR RESPONSE 1 0.0011
183 METASTASES TO ADRENALS 1 0.0011
184 BUNDLE BRANCH BLOCK 1 0.0011
185 INJECTION SITE ULCER 1 0.0011
186 ANAPHYLACTIC SHOCK 27 0.0010
187 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
188 CYTOMEGALOVIRUS INFECTION 17 0.0010
189 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
190 IDIOSYNCRATIC DRUG REACTION 1 0.0010
191 MASTOIDITIS 1 0.0010
192 PYELONEPHRITIS ACUTE 2 0.0010
193 STAPHYLOCOCCAL SEPSIS 5 0.0010
194 HYPOFIBRINOGENAEMIA 1 0.0010
195 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
196 HYPOGONADISM 1 0.0010
197 ILEAL ULCER 1 0.0010
198 INFUSION RELATED REACTION 65 0.0010
199 FEBRILE NEUTROPENIA 64 0.0010
200 SKIN EROSION 3 0.0009
201 IDIOPATHIC URTICARIA 1 0.0009
202 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
203 PNEUMONIA STREPTOCOCCAL 1 0.0009
204 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
205 TUMOUR LYSIS SYNDROME 8 0.0009
206 CARDIAC AMYLOIDOSIS 1 0.0009
207 OTITIS MEDIA 3 0.0009
208 INTESTINAL ISCHAEMIA 5 0.0009
209 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
210 CYTOGENETIC ABNORMALITY 1 0.0009
211 DIFFICULTY IN WALKING 3 0.0009
212 PO2 DECREASED 1 0.0009
213 RETINAL DETACHMENT 8 0.0009
214 CEREBRAL VENTRICLE DILATATION 1 0.0009
215 MACROCYTOSIS 1 0.0009
216 HEPATIC CYTOLYSIS 11 0.0009
217 HYPERREFLEXIA 3 0.0009
218 BILIRUBIN CONJUGATED INCREASED 2 0.0009
219 FIBRIN D DIMER INCREASED 3 0.0008
220 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
221 HAEMATOMA MUSCLE 1 0.0008
222 CARDIAC DEATH 1 0.0008
223 RASH PUSTULAR 6 0.0008
224 BLADDER PROLAPSE 1 0.0008
225 MYOPATHY 7 0.0008
226 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
227 HYPERNATRAEMIA 4 0.0008
228 DERMATITIS EXFOLIATIVE 4 0.0008
229 EXCORIATION 2 0.0008
230 MALLORY-WEISS SYNDROME 1 0.0008
231 TONGUE OEDEMA 3 0.0008
232 DISSEMINATED TUBERCULOSIS 2 0.0008
233 IMMUNE RECONSTITUTION SYNDROME 1 0.0008
234 BRONCHOSPASM 11 0.0008
235 ABDOMINAL OPERATION 1 0.0008
236 HYPOGAMMAGLOBULINAEMIA 5 0.0008
237 NEUTROPHIL COUNT DECREASED 31 0.0008
238 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
239 MUCOUS MEMBRANE DISORDER 1 0.0007
240 RHINALGIA 2 0.0007
241 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
242 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
243 PERIODONTAL DISEASE 1 0.0007
244 PROTHROMBIN TIME SHORTENED 1 0.0007
245 CULTURE URINE POSITIVE 1 0.0007
246 SKIN TOXICITY 4 0.0007
247 GRAFT VERSUS HOST DISEASE 5 0.0007
248 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
249 DERMATITIS BULLOUS 5 0.0007
250 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
251 PULMONARY SEPSIS 1 0.0007
252 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
253 PARONYCHIA 3 0.0007
254 ACUTE ABDOMEN 1 0.0007
255 STRIDOR 2 0.0007
256 APRAXIA 1 0.0007
257 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
258 MYOSITIS 6 0.0007
259 HYPOSMIA 1 0.0007
260 ADHESION 1 0.0007
261 LARYNGEAL OEDEMA 4 0.0006
262 NEURITIS 1 0.0006
263 MYELITIS 1 0.0006
264 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
265 ERYTHEMA MULTIFORME 6 0.0006
266 OESOPHAGITIS 7 0.0006
267 LYMPHOPENIA 9 0.0006
268 NEONATAL DISORDER 1 0.0006
269 OPTIC NERVE DISORDER 1 0.0006
270 DISINHIBITION 1 0.0006
271 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
272 BACTERIAL SEPSIS 2 0.0006
273 CRYPTOCOCCOSIS 1 0.0006
274 VENOOCCLUSIVE LIVER DISEASE 3 0.0006
275 CORONAVIRUS INFECTION 4 0.0006
276 MITRAL VALVE PROLAPSE 1 0.0006
277 ENTEROBACTER INFECTION 1 0.0006
278 TOXIC ENCEPHALOPATHY 3 0.0006
279 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
280 FACIAL PARALYSIS 5 0.0006
281 AMYLOIDOSIS 1 0.0006
282 APLASTIC ANAEMIA 3 0.0006
283 MENINGITIS CRYPTOCOCCAL 1 0.0006
284 PSEUDOMONAL SEPSIS 1 0.0006
285 KYPHOSIS 1 0.0006
286 FEAR OF DISEASE 1 0.0006
287 INDURATION 1 0.0006
288 CONJUNCTIVAL HYPERAEMIA 2 0.0006
289 AORTIC VALVE STENOSIS 1 0.0006
290 CHRONIC GRAFT VERSUS HOST DISEASE 2 0.0006
291 CONTRAST MEDIA ALLERGY 1 0.0005
292 AMYLASE INCREASED 2 0.0005
293 DENTAL CARE 1 0.0005
294 GRANULOCYTE COUNT DECREASED 1 0.0005
295 NASAL OBSTRUCTION 1 0.0005
296 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
297 BLOOD BICARBONATE DECREASED 1 0.0005
298 LIP DISORDER 1 0.0005
299 HYPERTONIA 3 0.0005
300 METASTASES TO LUNG 6 0.0005
301 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
302 ATROPHY 1 0.0005
303 PURULENCE 1 0.0005
304 THROMBOTIC MICROANGIOPATHY 5 0.0005
305 AKATHISIA 7 0.0005
306 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
307 NASAL SEPTUM DEVIATION 1 0.0005
308 ORAL INFECTION 2 0.0005
309 APLASIA 1 0.0005
310 HYPOGEUSIA 1 0.0005
311 VENOUS THROMBOSIS 2 0.0005
312 COLOSTOMY 1 0.0005
313 HYPERAEMIA 1 0.0005
314 PNEUMONIA FUNGAL 2 0.0005
315 DIPLEGIA 1 0.0005
316 PATENT DUCTUS ARTERIOSUS 2 0.0005
317 PROTHROMBIN TIME PROLONGED 3 0.0005
318 HEPATITIS CHOLESTATIC 3 0.0005
319 DEVICE RELATED SEPSIS 1 0.0005
320 RASH MACULO-PAPULAR 11 0.0005
321 EAR HAEMORRHAGE 1 0.0005
322 HYPOTHERMIA 5 0.0005
323 MUSCLE CONTRACTURE 1 0.0005
324 SHOCK HAEMORRHAGIC 4 0.0005
325 AGRANULOCYTOSIS 9 0.0005
326 PHARYNGITIS 6 0.0005
327 LIVEDO RETICULARIS 1 0.0005
328 PHYSICAL ASSAULT 1 0.0005
329 SHOCK 11 0.0005
330 ATRIAL TACHYCARDIA 1 0.0005
331 PHARYNGEAL ERYTHEMA 1 0.0005
332 ANAEMIA MACROCYTIC 1 0.0005
333 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
334 HEPATITIS ACUTE 3 0.0005
335 HERPES SIMPLEX 3 0.0005
336 MUCOSAL INFLAMMATION 12 0.0005
337 HYPOXIA 16 0.0005
338 NOSOCOMIAL INFECTION 1 0.0005
339 MIDDLE EAR EFFUSION 1 0.0005
340 ABDOMINAL ABSCESS 2 0.0005
341 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
342 CARDIAC FAILURE ACUTE 3 0.0004
343 RHINITIS ALLERGIC 2 0.0004
344 PNEUMOCYSTIS JIROVECI PNEUMONIA 1 0.0004
345 INFECTIOUS MONONUCLEOSIS 1 0.0004
346 PERIARTHRITIS 1 0.0004
347 LICHENOID KERATOSIS 1 0.0004
348 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
349 PNEUMONIA BACTERIAL 4 0.0004
350 APHTHOUS STOMATITIS 1 0.0004
351 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
352 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1 0.0004
353 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
354 BACTERAEMIA 5 0.0004
355 PULSE ABSENT 2 0.0004
356 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
357 LACUNAR INFARCTION 1 0.0004
358 FACE OEDEMA 7 0.0004
359 ORAL INTAKE REDUCED 1 0.0004
360 ADRENAL INSUFFICIENCY 5 0.0004
361 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
362 HAEMATOLOGICAL INFECTION 1 0.0004
363 RETINAL TEAR 1 0.0004
364 CARTILAGE INJURY 1 0.0004
365 MULTI-ORGAN FAILURE 7 0.0004
366 GENERALISED OEDEMA 5 0.0004
367 ORGANISING PNEUMONIA 2 0.0004
368 INJECTION SITE ABSCESS 1 0.0004
369 PERSECUTORY DELUSION 1 0.0004
370 HYDRONEPHROSIS 3 0.0004
371 PETIT MAL EPILEPSY 2 0.0004
372 CANCER PAIN 1 0.0004
373 PHLEBITIS 2 0.0004
374 DEVICE RELATED INFECTION 6 0.0004
375 HEPATOSPLENOMEGALY 1 0.0004
376 PHYSICAL DECONDITIONING 1 0.0004
377 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
378 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
379 MUCORMYCOSIS 1 0.0004
380 HEPATITIS TOXIC 1 0.0004
381 PERSONALITY DISORDER 1 0.0004
382 EXFOLIATIVE RASH 1 0.0004
383 PHARYNGOLARYNGEAL PAIN 2 0.0004
384 ANGIONEUROTIC OEDEMA 1 0.0004
385 TRANSPLANT REJECTION 3 0.0004
386 SEPTIC SHOCK 16 0.0004
387 BLOOD PHOSPHORUS INCREASED 1 0.0004
388 ACUTE CORONARY SYNDROME 3 0.0004
389 GASTRIC ULCER HAEMORRHAGE 2 0.0004
390 RASH MORBILLIFORM 1 0.0004
391 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
392 ACUTE PULMONARY OEDEMA 2 0.0004
393 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
394 OXYGEN SATURATION ABNORMAL 1 0.0004
395 GRANULOCYTOPENIA 2 0.0004
396 CARDIAC VALVE DISEASE 2 0.0003
397 PHARYNGEAL DISORDER 1 0.0003
398 BLOOD URIC ACID INCREASED 2 0.0003
399 GASTROENTERITIS 5 0.0003
400 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
401 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
402 GROWTH RETARDATION 1 0.0003
403 PURPURA 3 0.0003
404 DRUG ERUPTION 6 0.0003
405 PLEURISY 2 0.0003
406 CREPITATIONS 1 0.0003
407 BLOOD CULTURE POSITIVE 1 0.0003
408 OROPHARYNGEAL DISCOMFORT 3 0.0003
409 HYPERCAPNIA 1 0.0003
410 HEPATITIS B 2 0.0003
411 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
412 INTERSTITIAL LUNG DISEASE 16 0.0003
413 PROSTATITIS 1 0.0003
414 NERVE COMPRESSION 3 0.0003
415 FIBROSIS 1 0.0003
416 OXYGEN SATURATION DECREASED 18 0.0003
417 BLOOD CREATININE DECREASED 1 0.0003
418 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
419 HAEMATOTOXICITY 3 0.0003
420 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
421 HEPATITIS B REACTIVATION 1 0.0003
422 POLYMYALGIA RHEUMATICA 1 0.0003
423 PNEUMONIA VIRAL 1 0.0003
424 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
425 POSTURE ABNORMAL 1 0.0003
426 HEPATIC NEOPLASM 1 0.0003
427 INJECTION SITE INFECTION 1 0.0003
428 DEAFNESS NEUROSENSORY 1 0.0003
429 PEPTIC ULCER 1 0.0003
430 MENINGITIS 2 0.0003
431 ANXIETY DISORDER 1 0.0003
432 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
433 TOXIC SKIN ERUPTION 3 0.0003
434 BLOOD BILIRUBIN INCREASED 8 0.0003
435 HEPATIC FUNCTION ABNORMAL 11 0.0003
436 BRONCHOPNEUMONIA 1 0.0003
437 ECCHYMOSIS 2 0.0003
438 HEPATIC FIBROSIS 1 0.0003
439 PLATELET COUNT DECREASED 31 0.0003
440 NEUTROPENIA 39 0.0003
441 PANCYTOPENIA 16 0.0003
442 DEPRESSIVE SYMPTOM 1 0.0003
443 PULMONARY TOXICITY 2 0.0003
444 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
445 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
446 LEUKOENCEPHALOPATHY 1 0.0003
447 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
448 PROTEIN TOTAL DECREASED 1 0.0003
449 APHASIA 8 0.0003
450 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
451 EPILEPSY 8 0.0003
452 CHOLESTASIS 5 0.0003
453 JAUNDICE 7 0.0003
454 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
455 HAEMOLYSIS 2 0.0003
456 TACHYCARDIA 23 0.0003
457 ATRIOVENTRICULAR BLOCK 2 0.0003
458 APHTHOUS ULCER 2 0.0003
459 MUSCLE RUPTURE 1 0.0003
460 TORSADE DE POINTES 2 0.0003
461 POLYDIPSIA 1 0.0003
462 ATAXIA 3 0.0003
463 FURUNCLE 2 0.0003
464 BLOOD ALBUMIN DECREASED 2 0.0003
465 CHOLECYSTITIS 3 0.0003
466 CEREBRAL ATROPHY 1 0.0003
467 AZOTAEMIA 1 0.0003
468 MYELOSUPPRESSION 9 0.0002
469 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
470 LIVER DISORDER 11 0.0002
471 MYASTHENIA GRAVIS 2 0.0002
472 STOMATITIS 15 0.0002
473 DECUBITUS ULCER 2 0.0002
474 SMALL INTESTINAL OBSTRUCTION 3 0.0002
475 LEG AMPUTATION 1 0.0002
476 PHOTOSENSITIVITY REACTION 4 0.0002
477 PERITONITIS 5 0.0002
478 GASTROINTESTINAL PERFORATION 1 0.0002
479 HEMIPLEGIA 2 0.0002
480 ERYTHEMA 49 0.0002
481 HYPOKALAEMIA 11 0.0002
482 HALLUCINATIONS, MIXED 1 0.0002
483 AORTIC VALVE INCOMPETENCE 1 0.0002
484 HEPATIC PAIN 1 0.0002
485 ANURIA 2 0.0002
486 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
487 CHAPPED LIPS 1 0.0002
488 URINE OUTPUT DECREASED 2 0.0002
489 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
490 HERPES ZOSTER 13 0.0002
491 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
492 CARDIAC FAILURE 18 0.0002
493 THROMBOCYTOPENIA 25 0.0002
494 MENINGITIS ASEPTIC 1 0.0002
495 EAR DISORDER 1 0.0002
496 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
497 ANAPHYLACTIC REACTION 12 0.0002
498 PYREXIA 75 0.0002
499 HYPOMAGNESAEMIA 3 0.0002
500 SEPSIS 24 0.0002
501 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
502 FEELING HOT 13 0.0002
503 HYPOCALCAEMIA 4 0.0002
504 BLOOD PRESSURE DECREASED 14 0.0002
505 RASH ERYTHEMATOUS 10 0.0002
506 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
507 HYPOVOLAEMIC SHOCK 1 0.0002
508 HYPERTHYROIDISM 3 0.0002
509 NEURALGIA 5 0.0002
510 HORMONE LEVEL ABNORMAL 1 0.0002
511 HEPATOMEGALY 2 0.0002
512 INFLAMMATORY MARKER INCREASED 1 0.0002
513 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
514 HYPOTONIA 2 0.0002
515 HYPERAMMONAEMIA 1 0.0002
516 FLUID INTAKE REDUCED 1 0.0002
517 CORONARY ARTERY STENOSIS 1 0.0002
518 KLEBSIELLA INFECTION 1 0.0002
519 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
520 BONE MARROW FAILURE 4 0.0002
521 ENDOCARDITIS 1 0.0002
522 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
523 C-REACTIVE PROTEIN INCREASED 7 0.0002
524 PNEUMOTHORAX 3 0.0002
525 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
526 HYPERSENSITIVITY 35 0.0002
527 ANAL FISSURE 1 0.0002
528 ANAL ABSCESS 1 0.0002
529 GINGIVITIS 1 0.0002
530 THROAT TIGHTNESS 5 0.0002
531 CHEILITIS 1 0.0002
532 LUNG DISORDER 9 0.0002
533 HYDROCEPHALUS 1 0.0002
534 MELAENA 4 0.0002
535 PLEURAL EFFUSION 11 0.0002
536 COAGULOPATHY 3 0.0002
537 STEVENS-JOHNSON SYNDROME 4 0.0002
538 NECROSIS 1 0.0002
539 INTRACRANIAL PRESSURE INCREASED 1 0.0002
540 MALNUTRITION 2 0.0002
541 ANGIOPATHY 1 0.0002
542 BLOOD CALCIUM DECREASED 2 0.0002
543 STATUS EPILEPTICUS 2 0.0002
544 CIRCULATORY COLLAPSE 3 0.0002
545 MYOCARDIAL ISCHAEMIA 2 0.0002
546 MYOCARDITIS 2 0.0002
547 ENTEROCOLITIS 1 0.0002
548 PERICARDIAL EFFUSION 4 0.0002
549 ELECTROLYTE IMBALANCE 2 0.0002
550 CAESAREAN SECTION 2 0.0002
551 RASH MACULAR 6 0.0002
552 HYPOVOLAEMIA 1 0.0002
553 HYPERTRIGLYCERIDAEMIA 1 0.0002
554 LYMPHOCYTE COUNT DECREASED 3 0.0002
555 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
556 BRADYKINESIA 1 0.0002
557 COVID-19 PNEUMONIA 2 0.0002
558 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
559 URINARY INCONTINENCE 5 0.0002
560 ODYNOPHAGIA 1 0.0002
561 HYPERLIPIDAEMIA 2 0.0002
562 RESPIRATORY DISORDER 5 0.0002
563 RENAL IMPAIRMENT 14 0.0002
564 OEDEMA 9 0.0002
565 LEUKOCYTOSIS 3 0.0002
566 HYPERGLYCAEMIA 6 0.0002
567 INGUINAL HERNIA 1 0.0002
568 DERMATITIS ACNEIFORM 1 0.0002
569 MENISCUS INJURY 1 0.0002
570 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
571 HYPERCALCAEMIA 2 0.0002
572 ILEUS 2 0.0002
573 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
574 BLOOD SODIUM DECREASED 3 0.0002
575 ANAEMIA 30 0.0002
576 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
577 ANOREXIA 2 0.0002
578 APPLICATION SITE VESICLES 1 0.0002
579 ATRIAL FIBRILLATION 15 0.0002
580 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
581 POLYP 1 0.0002
582 ASPERGILLUS INFECTION 1 0.0002
583 IMMUNE SYSTEM DISORDER 2 0.0002
584 MALIGNANT MELANOMA 2 0.0001
585 FLUSHING 15 0.0001
586 HYPERHIDROSIS 19 0.0001
587 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
588 SEIZURE 17 0.0001
589 PNEUMONITIS 4 0.0001
590 HAEMOGLOBIN DECREASED 15 0.0001
591 CROHN'S DISEASE 1 0.0001
592 NEPHROTIC SYNDROME 1 0.0001
593 HYPERTRANSAMINASAEMIA 1 0.0001
594 FORMICATION 1 0.0001
595 DISEASE PROGRESSION 17 0.0001
596 CARDIO-RESPIRATORY ARREST 6 0.0001
597 EXTRASYSTOLES 1 0.0001
598 HYPONATRAEMIA 8 0.0001
599 METASTASIS 1 0.0001
600 RED BLOOD CELL COUNT DECREASED 4 0.0001
601 PARALYSIS 2 0.0001
602 HYPOTENSION 28 0.0001
603 CARDIOGENIC SHOCK 2 0.0001
604 DRUG INTERACTION 22 0.0001
605 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
606 BLOOD CREATININE INCREASED 9 0.0001
607 MOUTH HAEMORRHAGE 1 0.0001
608 ASCITES 4 0.0001
609 DYSURIA 5 0.0001
610 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
611 TRANSAMINASES INCREASED 3 0.0001
612 PULMONARY OEDEMA 6 0.0001
613 KETOACIDOSIS 1 0.0001
614 HAEMODYNAMIC INSTABILITY 1 0.0001
615 BOWEL MOVEMENT IRREGULARITY 1 0.0001
616 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
617 PHARYNGEAL OEDEMA 2 0.0001
618 LYMPHOMA 2 0.0001
619 LUNG INFECTION 2 0.0001
620 APNOEA 1 0.0001
621 ACUTE MYELOID LEUKAEMIA 2 0.0001
622 HAEMORRHAGIC STROKE 1 0.0001
623 CYANOSIS 2 0.0001
624 SCIATICA 2 0.0001
625 METABOLIC ACIDOSIS 4 0.0001
626 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
627 MUSCLE DISORDER 1 0.0001
628 POLYURIA 1 0.0001
629 ESCHERICHIA INFECTION 1 0.0001
630 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
631 EOSINOPHIL COUNT INCREASED 1 0.0001
632 LEUKOPENIA 6 0.0001
633 HAEMODIALYSIS 1 0.0001
634 PERICARDITIS 2 0.0001
635 INFUSION SITE ERYTHEMA 1 0.0001
636 HEPATITIS 3 0.0001
637 HAEMATURIA 4 0.0001
638 PYELONEPHRITIS 1 0.0001
639 RASH 50 0.0001
640 LUNG INFILTRATION 1 0.0001
641 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
642 BRADYCARDIA 6 0.0001
643 CARDIOTOXICITY 1 0.0001
644 GASTROINTESTINAL INFECTION 1 0.0001
645 PAIN OF SKIN 3 0.0001
646 LIP DRY 1 0.0001
647 CONSTIPATION 24 0.0001
648 PATHOGEN RESISTANCE 1 0.0001
649 SKIN LESION 3 0.0001
650 RESTLESSNESS 4 0.0001
651 IRON DEFICIENCY ANAEMIA 1 0.0001
652 GRAND MAL CONVULSION 1 0.0001
653 OEDEMA PERIPHERAL 13 0.0001
654 ABORTION INDUCED 1 0.0001
655 RENAL FAILURE 14 0.0001
656 GASTRIC ULCER 2 0.0001
657 PROTEINURIA 2 0.0001
658 ACUTE KIDNEY INJURY 16 0.0001
659 PULMONARY FIBROSIS 2 0.0001
660 HYPERCHOLESTEROLAEMIA 1 0.0001
661 AUTOIMMUNE DISORDER 1 0.0001
662 RENAL TUBULAR NECROSIS 1 0.0001
663 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
664 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
665 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
666 CELLULITIS 5 0.0001
667 TASTE DISORDER 2 0.0001
668 MOTOR DYSFUNCTION 1 0.0001
669 DEHYDRATION 13 0.0001
670 HELICOBACTER INFECTION 1 0.0001
671 INFLAMMATION 5 0.0001
672 HYPERBILIRUBINAEMIA 1 0.0001
673 EXPOSURE DURING PREGNANCY 6 0.0001
674 EYE DISCHARGE 1 0.0001
675 RHABDOMYOLYSIS 4 0.0001
676 PETECHIAE 1 0.0001
677 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
678 DERMATITIS 2 0.0001
679 FOLLICULITIS 1 0.0001
680 MOUTH ULCERATION 2 0.0001
681 DERMATITIS ATOPIC 5 0.0001
682 SKIN EXFOLIATION 8 0.0001
683 HALLUCINATION, VISUAL 2 0.0001
684 JOINT DISLOCATION 1 0.0001
685 RENAL PAIN 1 0.0001
686 HYPOTHYROIDISM 3 0.0001
687 BREAST PAIN 1 0.0001
688 MALAISE 40 0.0001
689 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
690 HYPERTENSIVE CRISIS 1 0.0001
691 RASH PAPULAR 2 0.0001
692 NEPHROPATHY TOXIC 1 0.0001
693 FISTULA 1 0.0001
694 CHROMATURIA 2 0.0001
695 REBOUND EFFECT 1 0.0001
696 PRURITUS 34 0.0001
697 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
698 IMPAIRED DRIVING ABILITY 1 0.0001
699 CHEST DISCOMFORT 9 0.0001
700 CONVULSION 5 0.0001
701 DELIRIUM 3 0.0001
702 DECREASED APPETITE 20 0.0001
703 EYELID OEDEMA 1 0.0001
704 POST PROCEDURAL HAEMORRHAGE 1 0.0001
705 LOSS OF CONSCIOUSNESS 11 0.0001
706 HYPERTENSION 18 0.0001
707 ARRHYTHMIA 4 0.0001
708 MYOCLONUS 1 0.0001
709 CEREBRAL HAEMORRHAGE 3 0.0001
710 MUSCLE RIGIDITY 1 0.0001
711 HEPATITIS C 1 0.0001
712 THERAPEUTIC RESPONSE DECREASED 5 0.0001
713 BURSITIS 1 0.0001
714 NOCTURIA 1 0.0001
715 FIBROMYALGIA 2 0.0001
716 VERTIGO 5 0.0001
717 NO THERAPEUTIC RESPONSE 1 0.0001
718 ABDOMINAL PAIN 19 0.0001
719 BRONCHITIS 6 0.0001
720 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
721 PNEUMONIA 26 0.0001
722 HALLUCINATION 6 0.0001
723 DERMATITIS ALLERGIC 1 0.0001
724 DYSPNOEA 45 0.0001
725 HYPOPHAGIA 2 0.0001
726 URTICARIA 13 0.0001
727 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
728 HAEMATOMA 2 0.0001
729 RESPIRATORY TRACT INFECTION 2 0.0001
730 PLATELET COUNT INCREASED 1 0.0001
731 NODULE 1 0.0001
732 SPEECH DISORDER 4 0.0001
733 BEDRIDDEN 1 0.0001
734 GASTRITIS 2 0.0001
735 INFECTION 11 0.0001
736 ORAL CANDIDIASIS 1 0.0001
737 PULMONARY CONGESTION 1 0.0001
738 PANCREATITIS 4 0.0001
739 DISTURBANCE IN ATTENTION 4 0.0001
740 DYSKINESIA 3 0.0001
741 GINGIVAL BLEEDING 1 0.0001
742 ACUTE HEPATIC FAILURE 1 0.0001
743 BACK PAIN 17 0.0001
744 RESPIRATORY DISTRESS 2 0.0001
745 FEELING COLD 2 0.0001
746 COORDINATION ABNORMAL 1 0.0001
747 APHONIA 1 0.0001
748 BLISTER 4 0.0001
749 PAIN IN JAW 2 0.0001
750 DIALYSIS 1 0.0001
751 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
752 ANGINA PECTORIS 2 0.0001
753 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
754 MYELODYSPLASTIC SYNDROME 1 0.0001
755 HYPOKINESIA 1 0.0001
756 RESPIRATORY FAILURE 5 0.0001
757 AGITATION 5 0.0001
758 ANGIOEDEMA 3 0.0001
759 CARDIOMYOPATHY 1 0.0001
760 HEPATIC FAILURE 2 0.0001
761 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
762 BLOOD COUNT ABNORMAL 1 0.0001
763 DISCOMFORT 4 0.0001
764 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
765 CHEST PAIN 12 0.0001
766 HYPOGLYCAEMIA 3 0.0001
767 BLOOD POTASSIUM INCREASED 1 0.0001
768 CHOLELITHIASIS 2 0.0001
769 MANIA 1 0.0001
770 STAPHYLOCOCCAL INFECTION 2 0.0001
771 COUGH 17 0.0001
772 DRUG LEVEL INCREASED 1 0.0001
773 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
774 SKIN DISORDER 2 0.0001
775 URINARY RETENTION 2 0.0001
776 BLOOD UREA INCREASED 1 0.0001
777 EYE PRURITUS 2 0.0001
778 FLUID RETENTION 3 0.0001
779 MUSCULOSKELETAL DISCOMFORT 1 0.0001
780 PARANOIA 1 0.0001
781 ABDOMINAL DISTENSION 6 0.0001
782 ORTHOSTATIC HYPOTENSION 1 0.0001
783 LOCAL SWELLING 1 0.0001
784 OFF LABEL USE 50 0.0001
785 NEUROTOXICITY 1 0.0001
786 EOSINOPHILIA 1 0.0001
787 COLD SWEAT 1 0.0001
788 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
789 LYMPHADENOPATHY 2 0.0001
790 HEAD DISCOMFORT 1 0.0001
791 GOUT 1 0.0001
792 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
793 NAUSEA 44 0.0001
794 RASH PRURITIC 3 0.0001
795 OSTEOMYELITIS 1 0.0001
796 CONJUNCTIVITIS 1 0.0001
797 BACTERIAL INFECTION 1 0.0001
798 HEPATIC CIRRHOSIS 1 0.0001
799 VOMITING 25 0.0001
800 PHOTOPHOBIA 1 0.0001
801 MUSCULAR WEAKNESS 6 0.0001
802 ACNE 4 0.0001
803 BLOOD URINE PRESENT 1 0.0001
804 PULMONARY EMBOLISM 5 0.0001
805 MUSCULOSKELETAL DISORDER 1 0.0001
806 DIABETES MELLITUS 4 0.0001
807 INCREASED APPETITE 1 0.0001
808 ACUTE RESPIRATORY FAILURE 1 0.0001
809 HERNIA 1 0.0001
810 DYSTONIA 1 0.0001
811 COVID-19 9 0.0001
812 ORAL HERPES 1 0.0001
813 CHILLS 6 0.0001
814 DIARRHOEA 33 0.0001
815 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
816 DISORIENTATION 2 0.0001
817 HAEMATOCRIT DECREASED 1 0.0001
818 BLOOD PRESSURE ABNORMAL 1 0.0001
819 PRESCRIBED UNDERDOSE 1 0.0001
820 PREGNANCY 1 0.0000
821 BODY TEMPERATURE INCREASED 1 0.0000
822 INSOMNIA 13 0.0000
823 OSTEOARTHRITIS 2 0.0000
824 RENAL FAILURE ACUTE 2 0.0000
825 EATING DISORDER 1 0.0000
826 PRURITUS GENERALISED 1 0.0000
827 FAECES DISCOLOURED 1 0.0000
828 AMNESIA 3 0.0000
829 CONDITION AGGRAVATED 14 0.0000
830 MENTAL DISORDER 2 0.0000
831 APPLICATION SITE PAIN 1 0.0000
832 HEPATOTOXICITY 1 0.0000
833 SOMNOLENCE 9 0.0000
834 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
835 THROAT IRRITATION 2 0.0000
836 APPLICATION SITE PRURITUS 1 0.0000
837 MUSCLE SPASMS 8 0.0000
838 NASOPHARYNGITIS 8 0.0000
839 OROPHARYNGEAL PAIN 4 0.0000
840 RENAL DISORDER 2 0.0000
841 SLEEP DISORDER 3 0.0000
842 COMA 2 0.0000
843 MULTIPLE SCLEROSIS 2 0.0000
844 BLOOD PRESSURE FLUCTUATION 1 0.0000
845 BLOOD GLUCOSE DECREASED 2 0.0000
846 DIABETIC KETOACIDOSIS 1 0.0000
847 PRESYNCOPE 1 0.0000
848 CEREBRAL INFARCTION 1 0.0000
849 LIVER INJURY 1 0.0000
850 DYSPEPSIA 4 0.0000
851 ABASIA 1 0.0000
852 DYSGEUSIA 3 0.0000
853 PNEUMONIA ASPIRATION 1 0.0000
854 SYNCOPE 4 0.0000
855 HOT FLUSH 3 0.0000
856 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
857 SINUSITIS 4 0.0000
858 DRUG RESISTANCE 1 0.0000
859 RASH GENERALISED 1 0.0000
860 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
861 MUSCULOSKELETAL PAIN 2 0.0000
862 APPLICATION SITE ERYTHEMA 1 0.0000
863 PARAESTHESIA 6 0.0000
864 JOINT STIFFNESS 1 0.0000
865 EAR INFECTION 1 0.0000
866 DRY SKIN 5 0.0000
867 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
868 LIMB INJURY 1 0.0000
869 PALLOR 1 0.0000
870 TREATMENT NONCOMPLIANCE 2 0.0000
871 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
872 VISION BLURRED 5 0.0000
873 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
874 RESPIRATORY ARREST 1 0.0000
875 TREATMENT FAILURE 3 0.0000
876 DIVERTICULITIS 1 0.0000
877 PROCEDURAL PAIN 1 0.0000
878 INFLUENZA 4 0.0000
879 HAEMOPTYSIS 1 0.0000
880 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
881 EYE IRRITATION 2 0.0000
882 PANCREATIC CARCINOMA 1 0.0000
883 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
884 DYSPHONIA 2 0.0000
885 BONE PAIN 2 0.0000
886 NASAL CONGESTION 2 0.0000
887 LABORATORY TEST ABNORMAL 1 0.0000
888 WHEEZING 2 0.0000
889 BLOOD POTASSIUM DECREASED 1 0.0000
890 PREMATURE BABY 1 0.0000
891 FALL 11 0.0000
892 SUICIDE ATTEMPT 2 0.0000
893 DRUG ADMINISTRATION ERROR 1 0.0000
894 EMOTIONAL DISORDER 1 0.0000
895 GYNAECOMASTIA 1 0.0000
896 LIMB DISCOMFORT 1 0.0000
897 NERVOUS SYSTEM DISORDER 1 0.0000
898 DYSPHAGIA 3 0.0000
899 NEUROPATHY PERIPHERAL 3 0.0000
900 MOVEMENT DISORDER 1 0.0000
901 HIP FRACTURE 1 0.0000
902 RHINORRHOEA 2 0.0000
903 CONFUSIONAL STATE 5 0.0000
904 LACTIC ACIDOSIS 1 0.0000
905 EYE DISORDER 1 0.0000
906 TREMOR 5 0.0000
907 LIP SWELLING 1 0.0000
908 ANGER 1 0.0000
909 HEPATIC ENZYME INCREASED 2 0.0000
910 ASTHENIA 11 0.0000
911 NEOPLASM PROGRESSION 1 0.0000
912 HYPERKALAEMIA 1 0.0000
913 HEART RATE DECREASED 1 0.0000
914 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
915 EYE SWELLING 1 0.0000
916 DYSPNOEA EXERTIONAL 1 0.0000
917 INTESTINAL OBSTRUCTION 1 0.0000
918 UNEVALUABLE EVENT 2 0.0000
919 COLITIS 1 0.0000
920 BLOOD PRESSURE INCREASED 4 0.0000
921 PLASMA CELL MYELOMA 1 0.0000
922 PALPITATIONS 3 0.0000
923 WEIGHT DECREASED 7 0.0000
924 BLINDNESS 1 0.0000
925 INFLUENZA LIKE ILLNESS 2 0.0000
926 ABDOMINAL PAIN UPPER 5 0.0000
927 DIZZINESS 12 0.0000
928 POLLAKIURIA 1 0.0000
929 ABDOMINAL DISCOMFORT 4 0.0000
930 URINARY TRACT INFECTION 4 0.0000
931 OVERDOSE 5 0.0000
932 BALANCE DISORDER 2 0.0000
933 MUSCULOSKELETAL STIFFNESS 2 0.0000
934 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
935 WEIGHT INCREASED 5 0.0000
936 GASTROINTESTINAL DISORDER 2 0.0000
937 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
938 BREAST CANCER 2 0.0000
939 BLOOD CHOLESTEROL INCREASED 1 0.0000
940 SWELLING 2 0.0000
941 OCULAR HYPERAEMIA 1 0.0000
942 DISEASE RECURRENCE 1 0.0000
943 PRODUCTIVE COUGH 1 0.0000
944 ECZEMA 1 0.0000
945 DRUG EFFECT DECREASED 1 0.0000
946 HAEMATOCHEZIA 1 0.0000
947 PAIN 11 0.0000
948 NECK PAIN 1 0.0000
949 EYE PAIN 1 0.0000
950 ASTHMA 2 0.0000
951 MYALGIA 3 0.0000
952 ANXIETY 5 0.0000
953 ARTHRALGIA 7 0.0000
954 CATARACT 1 0.0000
955 DRUG INEFFECTIVE 22 0.0000
956 IRRITABILITY 1 0.0000
957 VISUAL IMPAIRMENT 2 0.0000
958 HEADACHE 10 0.0000
959 DEEP VEIN THROMBOSIS 1 0.0000
960 PRODUCT DOSE OMISSION 1 0.0000
961 NEOPLASM MALIGNANT 1 0.0000
962 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
963 MEMORY IMPAIRMENT 2 0.0000
964 BURNING SENSATION 1 0.0000
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
966 EPISTAXIS 1 0.0000
967 HYPOAESTHESIA 2 0.0000
968 CHRONIC KIDNEY DISEASE 1 0.0000
969 INJECTION SITE SWELLING 1 0.0000
970 DEATH 11 0.0000
971 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
972 CARDIAC ARREST 1 0.0000
973 TOXICITY TO VARIOUS AGENTS 2 0.0000
974 MYOCARDIAL INFARCTION 2 0.0000
975 PRODUCT STORAGE ERROR 1 0.0000
976 DRUG WITHDRAWAL SYNDROME 1 0.0000
977 CARDIAC DISORDER 1 0.0000
978 BLOOD GLUCOSE INCREASED 2 0.0000
979 GAIT DISTURBANCE 2 0.0000
980 DRUG INTOLERANCE 1 0.0000
981 DEPRESSION 2 0.0000
982 JOINT SWELLING 1 0.0000
983 EMOTIONAL DISTRESS 1 0.0000
984 FATIGUE 6 0.0000
985 PAIN IN EXTREMITY 2 0.0000
986 PERIPHERAL SWELLING 1 0.0000
987 DRUG DOSE OMISSION 1 0.0000
988 PRODUCT USE ISSUE 1 0.0000
989 ALOPECIA 1 0.0000
990 INCORRECT DOSE ADMINISTERED 1 0.0000
991 FEELING ABNORMAL 1 0.0000